Periprosthetic inflammation: From the cellular level to clinical implications
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14110%2F25%3A00142267" target="_blank" >RIV/00216224:14110/25:00142267 - isvavai.cz</a>
Result on the web
<a href="https://academic.oup.com/jbmrplus/advance-article/doi/10.1093/jbmrpl/ziaf154/8257522" target="_blank" >https://academic.oup.com/jbmrplus/advance-article/doi/10.1093/jbmrpl/ziaf154/8257522</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1093/jbmrpl/ziaf154" target="_blank" >10.1093/jbmrpl/ziaf154</a>
Alternative languages
Result language
angličtina
Original language name
Periprosthetic inflammation: From the cellular level to clinical implications
Original language description
Periprosthetic inflammation is a crucial factor contributing to aseptic loosening, the leading cause of implant failures. Metallic debris, including nanoparticles, sub-micron particles, and ions, plays a central role in triggering inflammatory responses around orthopaedic implants. Exposure to the debris activates macrophages via Toll-like receptors (TLRs) and NOD-like receptors (NLRs), which in turn leads to the production of pro-inflammatory cytokines. This signalling cascade subsequently drives osteoclast activation, resulting in periprosthetic bone loss and, ultimately, implant loosening. Recent research has focused on strategies to prevent aseptic loosening by targeting the inflammation induced by metallic particles/ions. Pharmacological interventions aimed at modulating macrophage activation and inhibiting specific inflammatory pathways have shown promise in reducing osteoclast activity and excessive bone resorption. This review provides a comprehensive overview of the processes involved in the pathogenesis of periprosthetic inflammation, beginning with the release of metallic debris and its recognition by immune cells, followed by the inflammatory reactions that lead to osteoclastogenesis and bone loss. A detailed understanding of these molecular mechanisms is essential for the development of targeted approaches to prevent aseptic loosening, improve long-term patient outcomes, and alleviate the economic burden on healthcare systems.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30211 - Orthopaedics
Result continuities
Project
—
Continuities
S - Specificky vyzkum na vysokych skolach<br>I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2025
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
JBMR PLUS
ISSN
2473-4039
e-ISSN
2473-4039
Volume of the periodical
9
Issue of the periodical within the volume
11
Country of publishing house
GB - UNITED KINGDOM
Number of pages
14
Pages from-to
1-14
UT code for WoS article
001593825900001
EID of the result in the Scopus database
2-s2.0-105019528592